Cargando…

Activation of Invariant NKT Cells Exacerbates Experimental Visceral Leishmaniasis

We report that natural killer T (NKT) cells play only a minor physiological role in protection from Leishmania donovani infection in C57BL/6 mice. Furthermore, attempts at therapeutic activation of invariant NKT (iNKT) cells with α-galactosylceramide (α-GalCer) during L. donovani infection exacerbat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stanley, Amanda C., Zhou, Yonghong, Amante, Fiona H., Randall, Louise M., Haque, Ashraful, Pellicci, Daniel G., Hill, Geoff R., Smyth, Mark J., Godfrey, Dale I., Engwerda, Christian R.
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2008
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2265425/ https://www.ncbi.nlm.nih.gov/pubmed/18463695 http://dx.doi.org/10.1371/journal.ppat.1000028

Ejemplares similares

Combined Immune Therapy for the Treatment of Visceral Leishmaniasis
por: Faleiro, Rebecca J., et al.
Publicado: (2016)

Galectin-1 Impairs the Generation of Anti-Parasitic Th1 Cell Responses in the Liver during Experimental Visceral Leishmaniasis
por: Bunn, Patrick T., et al.
Publicado: (2017)

Immunity to Visceral Leishmaniasis
por: Ali, Nahid, et al.
Publicado: (2012)

TLR4 and NKT Cell Synergy in Immunotherapy against Visceral Leishmaniasis
por: Karmakar, Subir, et al.
Publicado: (2012)

VCAM-1 and VLA-4 Modulate Dendritic Cell IL-12p40 Production in Experimental Visceral Leishmaniasis
por: Stanley, Amanda C., et al.
Publicado: (2008)

A structural basis for selection and cross-species reactivity of the semi-invariant NKT cell receptor in CD1d/glycolipid recognition
por: Kjer-Nielsen, Lars, et al.
Publicado: (2006)

Differential antitumor immunity mediated by NKT cell subsets in vivo
por: Crowe, Nadine Y., et al.
Publicado: (2005)

Immune Regulation during Chronic Visceral Leishmaniasis
por: Faleiro, Rebecca J., et al.
Publicado: (2014)

Development of mucosal‐associated invariant T cells
por: Koay, Hui‐Fern, et al.
Publicado: (2018)

The role of mucosal-associated invariant T cells in visceral leishmaniasis
por: Moreira, Marcela de Lima, et al.
Publicado: (2022)

A Natural Killer T (NKT) Cell Developmental Pathway Involving a Thymus-dependent NK1.1(−)CD4(+) CD1d-dependent Precursor Stage
por: Pellicci, Daniel G., et al.
Publicado: (2002)

Intracellular Bacterial Infection and Invariant NKT Cells
por: Emoto, Masashi, et al.
Publicado: (2009)

Critical Roles for LIGHT and Its Receptors in Generating T Cell-Mediated Immunity during Leishmania donovani Infection
por: Stanley, Amanda C., et al.
Publicado: (2011)

Type I Interferons Suppress Anti-parasitic Immunity and Can Be Targeted to Improve Treatment of Visceral Leishmaniasis
por: Kumar, Rajiv, et al.
Publicado: (2020)

Humans Lack iGb3 Due to the Absence of Functional iGb3-Synthase: Implications for NKT Cell Development and Transplantation
por: Christiansen, Dale, et al.
Publicado: (2008)

Invariant NKT Cells: Regulation and Function during Viral Infection
por: Juno, Jennifer A., et al.
Publicado: (2012)

CD4(+) Natural Regulatory T Cells Prevent Experimental Cerebral Malaria via CTLA-4 When Expanded In Vivo
por: Haque, Ashraful, et al.
Publicado: (2010)

New ways to turn on NKT cells
por: Godfrey, Dale Ian, et al.
Publicado: (2011)

Invariant NKT cells: Killers and conspirators against cancer
por: Bassiri, Hamid, et al.
Publicado: (2013)

Improved Detection of Cytokines Produced by Invariant NKT Cells
por: Sag, Duygu, et al.
Publicado: (2017)

504 Participation of Invariant NKT Cells (Vα24Jα18) during Asthma Exacerbation in Children
por: Carpio-Pedroza, Juan Carlos, et al.
Publicado: (2012)

Visceral leishmaniasis
por: Sundar, Shyam
Publicado: (2015)

IL-21 Modulates Activation of NKT Cells in Patients with Stage IV Malignant Melanoma
por: Coquet, Jonathan M, et al.
Publicado: (2013)

Invariant NKT Cell Response to Dengue Virus Infection in Human
por: Matangkasombut, Ponpan, et al.
Publicado: (2014)

Invariant NKT Cells as Novel Targets for Immunotherapy in Solid Tumors
por: Pilones, Karsten A., et al.
Publicado: (2012)

Effects of Invariant NKT Cells on Parasite Infections and Hygiene Hypothesis
por: Yang, Jun-Qi, et al.
Publicado: (2016)

Novel Approaches to Exploiting Invariant NKT Cells in Cancer Immunotherapy
por: Wolf, Benjamin J., et al.
Publicado: (2018)

Sequential activation of NKT cells and NK cells provides effective innate immunotherapy of cancer
por: Smyth, Mark J., et al.
Publicado: (2005)

The reemergence of visceral leishmaniasis in Brazil.
por: Arias, J R, et al.
Publicado: (1996)

Congenital Visceral Leishmaniasis
por: Boehme, Catharina C., et al.
Publicado: (2006)

Treatment of Visceral Leishmaniasis
por: Moore, E M, et al.
Publicado: (2010)

Immunobiology of visceral leishmaniasis
por: Kumar, Rajiv, et al.
Publicado: (2012)

Epidemiology of visceral leishmaniasis
por: Ready, Paul D
Publicado: (2014)

Mouse Invariant Monoclonal Antibody NKT14: A Novel Tool to Manipulate iNKT Cell Function In Vivo
por: Scheuplein, Felix, et al.
Publicado: (2015)

Relationship between treatment regimens for visceral leishmaniasis and development of post-kala-azar dermal leishmaniasis and visceral leishmaniasis relapse: A cohort study from Bangladesh
por: Mondal, Dinesh, et al.
Publicado: (2019)

Vaccines to prevent leishmaniasis
por: Kumar, Rajiv, et al.
Publicado: (2014)

Invariant NKT Cells as Initiators, Licensors, and Facilitators of the Adaptive Immune Response
por: Stein-Streilein, Joan
Publicado: (2003)

Invariant NKT cells are required for airway inflammation induced by environmental antigens
por: Wingender, Gerhard, et al.
Publicado: (2011)

Exploiting invariant NKT cells to promote T-cell responses to cancer vaccines
por: Hunn, Martin K., et al.
Publicado: (2013)

Eomes transcription factor is required for the development and differentiation of invariant NKT cells
por: Shimizu, Kanako, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_rnqeq28h2kdvfl2abv6h74msvv